|Articles|November 1, 2011
- Pharmaceutical Executive-11-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2011
Red Light on the Access Autobahn
Advertisement
Articles in this issue
about 14 years ago
Plant Managementabout 14 years ago
The Road from No. 20about 14 years ago
Five Yearsabout 14 years ago
Spotlight on OTCsabout 14 years ago
Invarabout 14 years ago
Europe Tackles 'Advertising in Disguise' Fearsabout 14 years ago
The Drug Shortages Struggleabout 14 years ago
Euroserviceabout 14 years ago
Pharma's Visit to the Plastic Surgeonabout 14 years ago
The Pharma Revolution RecalibratedNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
2
FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma
3
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
4
Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits
5